Tenofovir

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 4, 2024.

Return to the list of Patented Medicine Litigation page.

COMPLERA, VEMLIDY, VIREAD – Gilead Sciences Canada Inc. (NOC Search)

Patents:

2261619: TEVA, APOTEX
2298059: TEVA, APOTEX
2298619: TEVA
2454416: , APOTEX
2454424: APOTEX,
2461463: APOTEX
2464241:
2845553: PHARMASCIENCE, APOTEX, JAMP,
2990210: JAMP, , APOTEX, PHARMASCIENCE

Unknown/Other

PM(NOC) – T-1555-22 – T-1556-22

APOTEX

Infringement – T-1004-22 (2022 FC 1460) – T-1006-22
PM(NOC) – A-311-16 – T-1694-14 (2016 FC 857)

JAMP

PM(NOC) – T-1484-22 (2024 FC 344, 2023 FC 1141) – T-1607-22

PHARMASCIENCE

PM(NOC) – T-2133-22 – T-2139-22

TEVA

Appeal – A-33-15 (2016 FCA 176) – A-499-14
Infringement – T-1888-15 (2016 FC 336, 2016 FC 31)
PM(NOC) – A-494-14 – A-60-14 – A-61-14 – A-62-14 – T-1708-12 (2013 FC 1272) – T-280-12 (2013 FC 1271) – T-8-12 (2014 FC 950, 2013 FC 1270)
Impeachment – T-1529-12

Return to the Patented Medicine Litigation page.

Tenofovir

Canadian Intellectual Property